What Know About This Fund's Ultragenyx Purchase Move
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
When To Assess Your Retirement Strategy
Knowing when to assess your retirement strategy ensures your financial plan remains effective. Regular evaluations can lead to better outcomes.
21,973 articlesCoreWeave Stock Tumbling Today: What Investors Should Know
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
Fund Builds Million Commerce Stake as SPS Stock Slumps
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Two Stocks with Monster Potential to Weather Chaos
In a volatile world, a few dominant companies offer steadier upside. This article spotlights two stocks with monster ...
Prediction: Broadcom's June Earnings Could Dwarf Tech Stocks This Quarter
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
U.S. Government Blocked Anthropic's AI: Impact on Crypto
Regulatory moves around AI can move crypto markets faster than a breakthrough in code. This piece explains what happe...
Shares Thomson Reuters Surging: AI Momentum Drives Stock
A sharp move in Thomson Reuters stock has investors buzzing. AI-powered products and enterprise deals are at the hear...
Missed April's Rally? These 3 Stocks Look Bargains
When the AI spotlight faded in April, some top names cooled off just enough to become bargains. This piece breaks dow...
Vistra Constellation Energy: Revenue Face-Off for Investors
Two energy giants, two distinct revenue playbooks. This article unpacks how Vistra and Constellation Energy produce i...
Forget SpaceX: Two AI Space Stocks to Buy and Hold
The hype around SpaceX often drowns out solid opportunities in AI-powered space companies. This guide shines a light ...
Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Oklo Stock Climbing Higher This Week: Driving Factors
Oklo stock climbing higher this week is driven by regulatory progress on its Aurora reactor and broader interest in a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status